"/> Novus Biologicals™ Peptide bloquant d’anticorps OC… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps OCIAD1

Réf. : BL-RE-049705Réf. fabricant : 18296628 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
54940
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-76242. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

16 amino acids near the amino terminus of OCIAD1. Source: Synthetic (Accession #: NP_060300) The OCIAD1 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-049705
Réf. fabricant18296628
Gene ID (Entrez)54940
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-76242. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneAsrij, MGC111072, OCIA domain containing 1, OCIA domain-containing protein 1, OCIAFLJ20455, Ovarian carcinoma immunoreactive antigen, TPA018
Symbole de gène(s)OCIAD1
Type de produitOCIAD1
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne16 amino acids near the amino terminus of OCIAD1
Une question, une configuration particulière ?
Contactez-nous pour un devis.